Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-156728
Filing Date
2015-04-29
Accepted
2015-04-29 16:41:10
Documents
7
Period of Report
2015-06-08
Effectiveness Date
2015-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d916772ddef14a.htm DEF 14A 798772
2 GRAPHIC g916772g12c22.jpg GRAPHIC 5552
3 GRAPHIC g916772pc_01anew.jpg GRAPHIC 31152
4 GRAPHIC g916772pc_01bnew.jpg GRAPHIC 51613
5 GRAPHIC g916772pc_01c.jpg GRAPHIC 5702
6 GRAPHIC g916772pc_01d.jpg GRAPHIC 15253
7 GRAPHIC g916772pc_01e.jpg GRAPHIC 32144
  Complete submission text file 0001193125-15-156728.txt   995637
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31918 | Film No.: 15813377
SIC: 2836 Biological Products, (No Diagnostic Substances)